2815 - Morquio Syndrome: Drugs (Answered)

Greg Mulholland
To ask the Secretary of State for Health, for what reasons NHS England's announcement on whether it will grant interim funding for the Vimizim drug has been rescheduled from 25 to 30 June 2015.

George Freeman

The decision on the interim funding of Vimizim (elosulfase alfa) will be made by NHS England by the end of June 2015. NHS England has not scheduled a date for the announcement of this decision.

Clinical commissioning policies setting out NHS England’s position on investing in a number of specific specialised services and treatments will be published on the NHS England website as soon as possible following final decisions being taken.

In addition to publishing clinical commissioning policies on its website, NHS England will be engaging with stakeholder groups with particular interest in specific policies to ensure that they are aware of NHS England’s decisions and their implications for patients and service users. A communications plan is currently in development.